As the demand for app-based services grows, now may be the time to invest in UX research to identify needed improvements and enhancements.
Now is the ideal time to improve the UX of your mobile app
read more
Back to team page
Jim Kershner
Director
Jim has 20+ years of medical device product development experience, ranging from orthopedic implants and surgical instruments, to endovascular products, to drug delivery systems. Jim conducts and manages both UX and human factors projects in the healthcare space. Jim has a BS in Physics from Appalachian State University and an MEngSc in Biomedical Engineering from the University of New South Wales.
Bold facts
Learn more about
Jim
Something unique about you summed up in one sentence:
I have an inexplicable obsession with earth-sheltered homes, and have a mini library of associated design books, architectural references, and construction details.
Your favorite part of working at Bold Insight
The culture of a family team (like the Partridge Family, but less dorky).
In your spare time (or if you had spare time), you would absolutely do this:
Take a historic train tour of Great Britain.
Long-term personal or professional goal?
To help develop the next generation of UX researchers at Bold Insight.
How long have you been in the UX field?
20+ years
Your ultimate celebrity dinner party guest list would include:
SNL-era Will Ferrell, Living Color-era Jim Carrey, 30 Rock-era Tina Fey, I Love Lucy-era Lucille Ball
Your favorite city in the world is...and why?
Paris, for the food, the culture, and the people.
Any other facts to share?
I took up archery and gave up golf because I’m terrible at golf and it makes me angry.
Read Jim's bold insights
- Bold Insight presents with Stryker, Genentech, and AbbVie at the HFES Healthcare Symposium
- Human factors optimization: How to leverage HF researchers in your medtech team
- Bold Insight featured in Packaging Digest on when to finalize design elements of your medical device packaging
- What medtech design teams need to know about AI regulations
- 3 crucial aspects of submitting a successful human factors engineering package to the FDA
- Bold Insight to present on IFU design, digital telemetry, and other human factors topics at HFES Healthcare Symposium
Read our team’s latest bold insights
Human factors research in the times of COVID
Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.